A Phase 2 Study of Simtuzumab in Patients With Primary, Post-Polycythaemia Vera or Post-Essential Thrombocythaemia Myelofibrosis

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.14501
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Antiplatelet Drugs for Polycythaemia Vera and Essential Thrombocythaemia

Cochrane Database of Systematic Reviews
2013English

Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2009English

Fortgeschrittene Post-Polycythaemia-Vera-Myelofibrose

Swiss Medical Forum ‒ Schweizerisches Medizin-Forum
2014English

Erythromelalgic Thrombotic Thrombocythemia (ETT) and Hemorrhagic Trombocythemia (HT) in Patients With Essential Thrombocythaemia (ET) and Polycythaemia Vera (PV)

Journal of Hematology & Thromboembolic Diseases
2014English

The Role of Zinc Protoporphyrin Measurement in the Differentiation Between Primary Myelofibrosis and Essential Thrombocythaemia

Annals of Hematology
MedicineHematology
2010English

Massive Bone Marrow Necrosis and Postnecrotic Myelofibrosis in a Patient With Primary Thrombocythaemia.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1994English

Survival of Polycythaemia Vera Patients Treated With Radioactive Phosphorus.

BMJ
1967English

Morphologic and Cytogenetic Differences Between Post-Polycythemic Myelofibrosis and Primary Myelofibrosis in Fibrotic Stage

Modern Pathology
Forensic MedicinePathology
2013English

Hyperuricaemia in Polycythaemia Vera

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1966English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy